Annals of Hematology

, Volume 88, Issue 10, pp 957–965 | Cite as

Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men

Original Article


This study analysed the influence of extrinsic factors on the phenotypic expression of HFE gene variants in ethnic Danish men. A cohort of 6,020 men aged 30-53 years was screened for HFE C282Y, H63D and S65C variants. Serum iron, serum transferrin, transferrin saturation, and serum ferritin were analysed in 1,452 men and 1,294 men completed a questionnaire on factors, which could influence iron balance. The C282Y allele was present in 5.6%, H63D in 12.8% and S65C in 1.8% of the men. In the entire series, 3% had elevated iron status markers (transferrin saturation ≥50%, ferritin ≥300 μg/L). Self-reported liver disease had an elevating effect and peptic ulcer a lowering effect on iron status markers. Age increased the fraction of men with elevated ferritin from 8.3% at 32-38 years to 16.2% at 46-53 years of age (p = 0.002). Blood donation had a lowering effect on iron status markers (p = 0.0001). Alcohol consumption elevated serum iron and serum ferritin (p = 0.001). Meat consumption had an elevating effect (p = 0.02) and milk consumption a lowering effect (p = 0.03) on serum ferritin. There was no influence of vitamin-mineral tablets on iron status markers. In adjusted logistic regression analysis, the HFE genotype had the highest impact on iron status markers; high alcohol consumption was significantly associated with elevated transferrin saturation. High age and high alcohol consumption were significantly associated with elevated ferritin and high egg consumption and blood donation was significantly associated with normal ferritin levels. In conclusion, the expressivity of HFE variant phenotypes in Danish men was enhanced by alcohol and meat consumption and decreased by milk and egg consumption and blood donation.


Expressivity Genotypes Hemochromatosis Mutations Penetrance Scandinavia 



The authors express their gratitude to the staff at the Department of Clinical Biochemistry at Næstved Hospital for their entusiasm at the performance of this study, especially to Chief Physician Arne Bremmelgaard for devoted support and guidance and to Laboratory Technician Gitte Vedel Melsen for excellent technical assistance.


  1. 1.
    Milman N, Pedersen P, Steig T, Byg K-E, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744PubMedCrossRefGoogle Scholar
  2. 2.
    Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47PubMedCrossRefGoogle Scholar
  3. 3.
    Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment. Cambrigde University Press, Cambrigde, pp 15–41 ISBN 0 521 593808Google Scholar
  4. 4.
    Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830–836PubMedGoogle Scholar
  5. 5.
    Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724PubMedCrossRefGoogle Scholar
  6. 6.
    McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L (1999) Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 107:30–37PubMedCrossRefGoogle Scholar
  7. 7.
    McLaren GD, McLaren CE, Adams PC, Barton JC, Reboussin DM, Gordeuk VR, Acton RT, Harris EL, Speechley MR, Sholinsky P, Dawkins FW, Snively BM, Vogt TM, Eckfeldt JH, for the Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators (2008) Clinical manifestations of hemochromatosis in HFE C282Y Homozygotes identified by screening. Can J Gastroenterol 22:923–930PubMedGoogle Scholar
  8. 8.
    Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL (2002) Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 29:41–47PubMedCrossRefGoogle Scholar
  9. 9.
    Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10, 500 blood donors. Br J Haematol 114:474–484PubMedCrossRefGoogle Scholar
  10. 10.
    Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218PubMedCrossRefGoogle Scholar
  11. 11.
    Pedersen P, Milman N. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants. Ann Hematol 2009; doi: 10.1007/s00277-008-0679-1
  12. 12.
    Allen KJ, Gurrin LC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM (2008) Iron overload related disease in HFE hereditary hemochromatosis. N Engl J Med 358:221–230PubMedCrossRefGoogle Scholar
  13. 13.
    Elsass P, Pedersen P, Husum K, Milman N (2008) Assessment of the psychological effects of genetic screening of hereditary hemochromatosis. Ann Hematol 87:397–404PubMedCrossRefGoogle Scholar
  14. 14.
    Pedersen P, Melsen GV, Milman N (2008) Frequencies of the haemochromatosis (HFE) gene variants C828Y, H63D and S65C in 6, 020 ethnic Danish men. Ann Hematol 87:735–740PubMedCrossRefGoogle Scholar
  15. 15.
    Milman N (1991) Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele. Eur J Haematol 47:292–298PubMedGoogle Scholar
  16. 16.
    Milman N (1996) Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 63:103–135PubMedCrossRefGoogle Scholar
  17. 17.
    Milman N, Clausen J, Byg K-E (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 77:13–19PubMedCrossRefGoogle Scholar
  18. 18.
    Andersen RV, Tybjærg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG (2004) Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:2914–2919PubMedCrossRefGoogle Scholar
  19. 19.
    Milman N, Byg K-E, Ovesen L, Kirchhoff M, Jürgensen KS (2002) Iron status in Danish men 1984–94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 68:332–340PubMedCrossRefGoogle Scholar
  20. 20.
    Lyhne N, Christensen T, Groth MV, Fagt S, Biltoft-jensen A, Hartkoop H, et al. Danskernes Kostvaner 2000-2002. Hovedresultater (Danish Nutrition Habits 2000-2002. Main results) DFVF Publication no. 11. ISBN 87-988795-5-3. Silkeborg 2005Google Scholar
  21. 21.
    Cook (2000) Hemochromatosis: effect of iron fortification of foods. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 535–543Google Scholar
  22. 22.
    Milman N, Kirchhoff M (1996) Relationship between serum ferritin, alcohol intake, and social status in 2235 Danish men and women. Ann Hematol 72:145–151PubMedCrossRefGoogle Scholar
  23. 23.
    Baynes RD (2000) Interaction of alcohol, iron and hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis. Genetics, pathophysiology, diagnosis And treatment. Cambrigde University Press, Cambrigde, pp 468–474 ISBN 0 521 593808Google Scholar
  24. 24.
    Moirand R, Lescoat G, Delamaire D, Lauvin L, Campion JP, Deugnier Y, Brissot P (1991) Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol Clin Exp Res 15:963–969PubMedCrossRefGoogle Scholar
  25. 25.
    Loreal O, Deugnier Y, Moirand R, Lauvin L, Guyader D, Jouanolle H, Turlin B, Lescoat G, Brissot P (1992) Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol 16:122–127PubMedCrossRefGoogle Scholar
  26. 26.
    Brissot P. Clinical spectrum of hepatic disease in hemochromatosis. In Barton JC, Edwards CQ (eds). Hemochromatosis. Genetics, pathophysiology, diagnosis And treatment. Cambrigde. Cambrigde University Press ISBN 0 521 593808: p 250-257Google Scholar
  27. 27.
    Milman N, Ovesen L, Byg K-E, Graudal N (1999) Iron status in Danes updated 1994. I: prevalence of iron deficiency and iron overload in 1332 men aged 40–70 years. Influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 78:393–400PubMedCrossRefGoogle Scholar
  28. 28.
    Milman N, Søndergaard M (1984) Iron stores in male blood donors: evaluation by serum ferritin. Transfusion 24:464–468PubMedCrossRefGoogle Scholar
  29. 29.
    Milman N, Kirchhoff M (1991) The influence of blood donation on iron stores assessed by serum ferritin and haemoglobin in a population survey of 1433 Danish males. Eur J Haematol 47:134–149PubMedGoogle Scholar
  30. 30.
    Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW (1990) Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 74:525–530PubMedCrossRefGoogle Scholar
  31. 31.
    Bergström E, Hernell O, Lönnerdal B, Persson LA (1995) Sex differences in iron stores of adolescents: what is normal? J Pediatr Gastroenterol Nutr 20:215–224PubMedGoogle Scholar
  32. 32.
    Barton JC, Conrad ME, Parmley RT (1983) Calcium inhibition of inorganic iron absorption in rats. Gastroenterology 84:90–101PubMedGoogle Scholar
  33. 33.
    Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C (1998) Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut 43:699–704PubMedCrossRefGoogle Scholar
  34. 34.
    Rossander-Hultén L, Brune M, Sandström B, Lönnerdal B, Hallberg L (1991) Competitive inhibition of iron absorption by manganese and zinc in humans. Am J Clin Nutr 54:152–156PubMedGoogle Scholar
  35. 35.
    O’Brien KO, Zavaleta N, Caulfield LE, Wen J, Abrams SA (2000) Prenatal iron supplements impair zinc absorption in pregnant Peruvian women. J Nutr 130:2251–2255PubMedGoogle Scholar
  36. 36.
    Grønbæk KE, Milman N, Skødt V (1995) Preclinical hereditary hemochromatosis - is there an indication for preventive screening? Ugeskr Laeger 157:4249–4250PubMedGoogle Scholar
  37. 37.
    Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E (2000) The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 35:1301–1307PubMedCrossRefGoogle Scholar
  38. 38.
    Hennigar GR, Greene WB, Walker EM, de Saussure C (1979) Hemochromatosis caused by excessive vitamin iron intake. Am J Pathol 96:611–623PubMedGoogle Scholar
  39. 39.
    Perez RF, Amigo EA, Gonzalez CP (1998) Hemochromatosis presenting as acute liver failure after iron supplementation. N Engl J Med 339:269–270CrossRefGoogle Scholar
  40. 40.
    Milman N, Rosenstock S, Andersen L, Jørgensen T, Bonnevie O (1998) Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiological survey comprising 2754 Danish adults. Gastroenterology 115:268–274PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of Clinical Biochemistry, Næstved HospitalUniversity of CopenhagenNæstvedDenmark

Personalised recommendations